 | • レポートコード：MRC2Q12-17361 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、薬物乱用分析管理のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 薬物乱用分析管理のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 薬物乱用分析管理の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 薬物乱用分析管理のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの薬物乱用分析管理の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の薬物乱用分析管理の売上および2028年までの予測に焦点を当てています。 薬物乱用分析管理のグローバル主要企業には、Siemens、Abbott、QuidelOrtho Corporation、Thermo Fisher Scientific、Horiba、Beckman Coulter、Ortho Clinical Diagnostics、Microgenics、MedTest DX、Carolina Liquid Chemistries、Cerilliant、American Bio Medica Corp、Clarity Diagnostics LLC、Diatron、Kova International、Lin-Zhi International Inc、JAS Diagnostics、Quasar Instruments、BTNX、Bio-Rad Laboratoriesなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 薬物乱用分析管理市場は、タイプとアプリケーションによって区分されます。世界の薬物乱用分析管理市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 液体、凍結乾燥、その他 【アプリケーション別セグメント】 病院、臨床、診断検査室、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 薬物乱用分析管理製品概要 - タイプ別市場（液体、凍結乾燥、その他） - アプリケーション別市場（病院、臨床、診断検査室、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の薬物乱用分析管理販売量予測2017-2028 - 世界の薬物乱用分析管理売上予測2017-2028 - 薬物乱用分析管理の地域別販売量 - 薬物乱用分析管理の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別薬物乱用分析管理販売量 - 主要メーカー別薬物乱用分析管理売上 - 主要メーカー別薬物乱用分析管理価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（液体、凍結乾燥、その他） - 薬物乱用分析管理のタイプ別販売量 - 薬物乱用分析管理のタイプ別売上 - 薬物乱用分析管理のタイプ別価格 ・アプリケーション別市場規模（病院、臨床、診断検査室、その他） - 薬物乱用分析管理のアプリケーション別販売量 - 薬物乱用分析管理のアプリケーション別売上 - 薬物乱用分析管理のアプリケーション別価格 ・北米市場 - 北米の薬物乱用分析管理市場規模（タイプ別、アプリケーション別） - 主要国別の薬物乱用分析管理市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの薬物乱用分析管理市場規模（タイプ別、アプリケーション別） - 主要国別の薬物乱用分析管理市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の薬物乱用分析管理市場規模（タイプ別、アプリケーション別） - 主要国別の薬物乱用分析管理市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の薬物乱用分析管理市場規模（タイプ別、アプリケーション別） - 主要国別の薬物乱用分析管理市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの薬物乱用分析管理市場規模（タイプ別、アプリケーション別） - 主要国別の薬物乱用分析管理市場規模（トルコ、サウジアラビア） ・企業情報 Siemens、Abbott、QuidelOrtho Corporation、Thermo Fisher Scientific、Horiba、Beckman Coulter、Ortho Clinical Diagnostics、Microgenics、MedTest DX、Carolina Liquid Chemistries、Cerilliant、American Bio Medica Corp、Clarity Diagnostics LLC、Diatron、Kova International、Lin-Zhi International Inc、JAS Diagnostics、Quasar Instruments、BTNX、Bio-Rad Laboratories ・産業チェーン及び販売チャネル分析 - 薬物乱用分析管理の産業チェーン分析 - 薬物乱用分析管理の原材料 - 薬物乱用分析管理の生産プロセス - 薬物乱用分析管理の販売及びマーケティング - 薬物乱用分析管理の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 薬物乱用分析管理の産業動向 - 薬物乱用分析管理のマーケットドライバー - 薬物乱用分析管理の課題 - 薬物乱用分析管理の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Drugs of Abuse Analysis Controls is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Drugs of Abuse Analysis Controls is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Drugs of Abuse Analysis Controls is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Drugs of Abuse Analysis Controls include Siemens, Abbott, QuidelOrtho Corporation, Thermo Fisher Scientific, Horiba, Beckman Coulter, Ortho Clinical Diagnostics, Microgenics and MedTest DX, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Drugs of Abuse Analysis Controls manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Drugs of Abuse Analysis Controls market. Further, it explains the major drivers and regional dynamics of the global Drugs of Abuse Analysis Controls market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Siemens
Abbott
QuidelOrtho Corporation
Thermo Fisher Scientific
Horiba
Beckman Coulter
Ortho Clinical Diagnostics
Microgenics
MedTest DX
Carolina Liquid Chemistries
Cerilliant
American Bio Medica Corp
Clarity Diagnostics LLC
Diatron
Kova International
Lin-Zhi International Inc
JAS Diagnostics
Quasar Instruments
BTNX
Bio-Rad Laboratories
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Drugs of Abuse Analysis Controls Segment by Type
Liquid
Lyophilized
Others
Drugs of Abuse Analysis Controls Segment by Application
Hospital
Clinical
Diagnostic Laboratories
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Drugs of Abuse Analysis Controls market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Drugs of Abuse Analysis Controls, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Drugs of Abuse Analysis Controls, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Drugs of Abuse Analysis Controls, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drugs of Abuse Analysis Controls sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Drugs of Abuse Analysis Controls market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Drugs of Abuse Analysis Controls sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Siemens, Abbott, QuidelOrtho Corporation, Thermo Fisher Scientific, Horiba, Beckman Coulter, Ortho Clinical Diagnostics, Microgenics and MedTest DX, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Drugs of Abuse Analysis Controls in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Drugs of Abuse Analysis Controls manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drugs of Abuse Analysis Controls sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Drugs of Abuse Analysis Controls Product Introduction
1.2 Market by Type
1.2.1 Global Drugs of Abuse Analysis Controls Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Liquid
1.2.3 Lyophilized
1.2.4 Others
1.3 Market by Application
1.3.1 Global Drugs of Abuse Analysis Controls Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinical
1.3.4 Diagnostic Laboratories
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Drugs of Abuse Analysis Controls Sales Estimates and Forecasts 2017-2028
2.2 Global Drugs of Abuse Analysis Controls Revenue Estimates and Forecasts 2017-2028
2.3 Global Drugs of Abuse Analysis Controls Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Drugs of Abuse Analysis Controls Sales by Region
2.4.1 Global Drugs of Abuse Analysis Controls Sales by Region (2017-2022)
2.4.2 Global Sales Drugs of Abuse Analysis Controls by Region (2023-2028)
2.5 Global Drugs of Abuse Analysis Controls Revenue by Region
2.5.1 Global Drugs of Abuse Analysis Controls Revenue by Region (2017-2022)
2.5.2 Global Drugs of Abuse Analysis Controls Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Drugs of Abuse Analysis Controls Sales by Manufacturers
3.1.1 Global Top Drugs of Abuse Analysis Controls Manufacturers by Sales (2017-2022)
3.1.2 Global Drugs of Abuse Analysis Controls Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Drugs of Abuse Analysis Controls in 2021
3.2 Global Drugs of Abuse Analysis Controls Revenue by Manufacturers
3.2.1 Global Drugs of Abuse Analysis Controls Revenue by Manufacturers (2017-2022)
3.2.2 Global Drugs of Abuse Analysis Controls Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Drugs of Abuse Analysis Controls Revenue in 2021
3.3 Global Drugs of Abuse Analysis Controls Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Drugs of Abuse Analysis Controls Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Drugs of Abuse Analysis Controls Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Drugs of Abuse Analysis Controls Sales by Type
4.1.1 Global Drugs of Abuse Analysis Controls Historical Sales by Type (2017-2022)
4.1.2 Global Drugs of Abuse Analysis Controls Forecasted Sales by Type (2023-2028)
4.1.3 Global Drugs of Abuse Analysis Controls Sales Market Share by Type (2017-2028)
4.2 Global Drugs of Abuse Analysis Controls Revenue by Type
4.2.1 Global Drugs of Abuse Analysis Controls Historical Revenue by Type (2017-2022)
4.2.2 Global Drugs of Abuse Analysis Controls Forecasted Revenue by Type (2023-2028)
4.2.3 Global Drugs of Abuse Analysis Controls Revenue Market Share by Type (2017-2028)
4.3 Global Drugs of Abuse Analysis Controls Price by Type
4.3.1 Global Drugs of Abuse Analysis Controls Price by Type (2017-2022)
4.3.2 Global Drugs of Abuse Analysis Controls Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Drugs of Abuse Analysis Controls Sales by Application
5.1.1 Global Drugs of Abuse Analysis Controls Historical Sales by Application (2017-2022)
5.1.2 Global Drugs of Abuse Analysis Controls Forecasted Sales by Application (2023-2028)
5.1.3 Global Drugs of Abuse Analysis Controls Sales Market Share by Application (2017-2028)
5.2 Global Drugs of Abuse Analysis Controls Revenue by Application
5.2.1 Global Drugs of Abuse Analysis Controls Historical Revenue by Application (2017-2022)
5.2.2 Global Drugs of Abuse Analysis Controls Forecasted Revenue by Application (2023-2028)
5.2.3 Global Drugs of Abuse Analysis Controls Revenue Market Share by Application (2017-2028)
5.3 Global Drugs of Abuse Analysis Controls Price by Application
5.3.1 Global Drugs of Abuse Analysis Controls Price by Application (2017-2022)
5.3.2 Global Drugs of Abuse Analysis Controls Price Forecast by Application (2023-2028)
6 North America
6.1 North America Drugs of Abuse Analysis Controls Market Size by Type
6.1.1 North America Drugs of Abuse Analysis Controls Sales by Type (2017-2028)
6.1.2 North America Drugs of Abuse Analysis Controls Revenue by Type (2017-2028)
6.2 North America Drugs of Abuse Analysis Controls Market Size by Application
6.2.1 North America Drugs of Abuse Analysis Controls Sales by Application (2017-2028)
6.2.2 North America Drugs of Abuse Analysis Controls Revenue by Application (2017-2028)
6.3 North America Drugs of Abuse Analysis Controls Market Size by Country
6.3.1 North America Drugs of Abuse Analysis Controls Sales by Country (2017-2028)
6.3.2 North America Drugs of Abuse Analysis Controls Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Drugs of Abuse Analysis Controls Market Size by Type
7.1.1 Europe Drugs of Abuse Analysis Controls Sales by Type (2017-2028)
7.1.2 Europe Drugs of Abuse Analysis Controls Revenue by Type (2017-2028)
7.2 Europe Drugs of Abuse Analysis Controls Market Size by Application
7.2.1 Europe Drugs of Abuse Analysis Controls Sales by Application (2017-2028)
7.2.2 Europe Drugs of Abuse Analysis Controls Revenue by Application (2017-2028)
7.3 Europe Drugs of Abuse Analysis Controls Market Size by Country
7.3.1 Europe Drugs of Abuse Analysis Controls Sales by Country (2017-2028)
7.3.2 Europe Drugs of Abuse Analysis Controls Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Drugs of Abuse Analysis Controls Market Size by Type
8.1.1 Asia Pacific Drugs of Abuse Analysis Controls Sales by Type (2017-2028)
8.1.2 Asia Pacific Drugs of Abuse Analysis Controls Revenue by Type (2017-2028)
8.2 Asia Pacific Drugs of Abuse Analysis Controls Market Size by Application
8.2.1 Asia Pacific Drugs of Abuse Analysis Controls Sales by Application (2017-2028)
8.2.2 Asia Pacific Drugs of Abuse Analysis Controls Revenue by Application (2017-2028)
8.3 Asia Pacific Drugs of Abuse Analysis Controls Market Size by Region
8.3.1 Asia Pacific Drugs of Abuse Analysis Controls Sales by Region (2017-2028)
8.3.2 Asia Pacific Drugs of Abuse Analysis Controls Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Drugs of Abuse Analysis Controls Market Size by Type
9.1.1 Latin America Drugs of Abuse Analysis Controls Sales by Type (2017-2028)
9.1.2 Latin America Drugs of Abuse Analysis Controls Revenue by Type (2017-2028)
9.2 Latin America Drugs of Abuse Analysis Controls Market Size by Application
9.2.1 Latin America Drugs of Abuse Analysis Controls Sales by Application (2017-2028)
9.2.2 Latin America Drugs of Abuse Analysis Controls Revenue by Application (2017-2028)
9.3 Latin America Drugs of Abuse Analysis Controls Market Size by Country
9.3.1 Latin America Drugs of Abuse Analysis Controls Sales by Country (2017-2028)
9.3.2 Latin America Drugs of Abuse Analysis Controls Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Drugs of Abuse Analysis Controls Market Size by Type
10.1.1 Middle East and Africa Drugs of Abuse Analysis Controls Sales by Type (2017-2028)
10.1.2 Middle East and Africa Drugs of Abuse Analysis Controls Revenue by Type (2017-2028)
10.2 Middle East and Africa Drugs of Abuse Analysis Controls Market Size by Application
10.2.1 Middle East and Africa Drugs of Abuse Analysis Controls Sales by Application (2017-2028)
10.2.2 Middle East and Africa Drugs of Abuse Analysis Controls Revenue by Application (2017-2028)
10.3 Middle East and Africa Drugs of Abuse Analysis Controls Market Size by Country
10.3.1 Middle East and Africa Drugs of Abuse Analysis Controls Sales by Country (2017-2028)
10.3.2 Middle East and Africa Drugs of Abuse Analysis Controls Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Siemens
11.1.1 Siemens Corporation Information
11.1.2 Siemens Overview
11.1.3 Siemens Drugs of Abuse Analysis Controls Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Siemens Drugs of Abuse Analysis Controls Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Siemens Recent Developments
11.2 Abbott
11.2.1 Abbott Corporation Information
11.2.2 Abbott Overview
11.2.3 Abbott Drugs of Abuse Analysis Controls Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Abbott Drugs of Abuse Analysis Controls Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Abbott Recent Developments
11.3 QuidelOrtho Corporation
11.3.1 QuidelOrtho Corporation Corporation Information
11.3.2 QuidelOrtho Corporation Overview
11.3.3 QuidelOrtho Corporation Drugs of Abuse Analysis Controls Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 QuidelOrtho Corporation Drugs of Abuse Analysis Controls Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 QuidelOrtho Corporation Recent Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Corporation Information
11.4.2 Thermo Fisher Scientific Overview
11.4.3 Thermo Fisher Scientific Drugs of Abuse Analysis Controls Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Thermo Fisher Scientific Drugs of Abuse Analysis Controls Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Thermo Fisher Scientific Recent Developments
11.5 Horiba
11.5.1 Horiba Corporation Information
11.5.2 Horiba Overview
11.5.3 Horiba Drugs of Abuse Analysis Controls Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Horiba Drugs of Abuse Analysis Controls Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Horiba Recent Developments
11.6 Beckman Coulter
11.6.1 Beckman Coulter Corporation Information
11.6.2 Beckman Coulter Overview
11.6.3 Beckman Coulter Drugs of Abuse Analysis Controls Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Beckman Coulter Drugs of Abuse Analysis Controls Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Beckman Coulter Recent Developments
11.7 Ortho Clinical Diagnostics
11.7.1 Ortho Clinical Diagnostics Corporation Information
11.7.2 Ortho Clinical Diagnostics Overview
11.7.3 Ortho Clinical Diagnostics Drugs of Abuse Analysis Controls Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Ortho Clinical Diagnostics Drugs of Abuse Analysis Controls Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Ortho Clinical Diagnostics Recent Developments
11.8 Microgenics
11.8.1 Microgenics Corporation Information
11.8.2 Microgenics Overview
11.8.3 Microgenics Drugs of Abuse Analysis Controls Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Microgenics Drugs of Abuse Analysis Controls Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Microgenics Recent Developments
11.9 MedTest DX
11.9.1 MedTest DX Corporation Information
11.9.2 MedTest DX Overview
11.9.3 MedTest DX Drugs of Abuse Analysis Controls Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 MedTest DX Drugs of Abuse Analysis Controls Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 MedTest DX Recent Developments
11.10 Carolina Liquid Chemistries
11.10.1 Carolina Liquid Chemistries Corporation Information
11.10.2 Carolina Liquid Chemistries Overview
11.10.3 Carolina Liquid Chemistries Drugs of Abuse Analysis Controls Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Carolina Liquid Chemistries Drugs of Abuse Analysis Controls Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Carolina Liquid Chemistries Recent Developments
11.11 Cerilliant
11.11.1 Cerilliant Corporation Information
11.11.2 Cerilliant Overview
11.11.3 Cerilliant Drugs of Abuse Analysis Controls Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Cerilliant Drugs of Abuse Analysis Controls Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Cerilliant Recent Developments
11.12 American Bio Medica Corp
11.12.1 American Bio Medica Corp Corporation Information
11.12.2 American Bio Medica Corp Overview
11.12.3 American Bio Medica Corp Drugs of Abuse Analysis Controls Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 American Bio Medica Corp Drugs of Abuse Analysis Controls Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 American Bio Medica Corp Recent Developments
11.13 Clarity Diagnostics LLC
11.13.1 Clarity Diagnostics LLC Corporation Information
11.13.2 Clarity Diagnostics LLC Overview
11.13.3 Clarity Diagnostics LLC Drugs of Abuse Analysis Controls Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Clarity Diagnostics LLC Drugs of Abuse Analysis Controls Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Clarity Diagnostics LLC Recent Developments
11.14 Diatron
11.14.1 Diatron Corporation Information
11.14.2 Diatron Overview
11.14.3 Diatron Drugs of Abuse Analysis Controls Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Diatron Drugs of Abuse Analysis Controls Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Diatron Recent Developments
11.15 Kova International
11.15.1 Kova International Corporation Information
11.15.2 Kova International Overview
11.15.3 Kova International Drugs of Abuse Analysis Controls Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Kova International Drugs of Abuse Analysis Controls Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Kova International Recent Developments
11.16 Lin-Zhi International Inc
11.16.1 Lin-Zhi International Inc Corporation Information
11.16.2 Lin-Zhi International Inc Overview
11.16.3 Lin-Zhi International Inc Drugs of Abuse Analysis Controls Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Lin-Zhi International Inc Drugs of Abuse Analysis Controls Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Lin-Zhi International Inc Recent Developments
11.17 JAS Diagnostics
11.17.1 JAS Diagnostics Corporation Information
11.17.2 JAS Diagnostics Overview
11.17.3 JAS Diagnostics Drugs of Abuse Analysis Controls Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 JAS Diagnostics Drugs of Abuse Analysis Controls Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 JAS Diagnostics Recent Developments
11.18 Quasar Instruments
11.18.1 Quasar Instruments Corporation Information
11.18.2 Quasar Instruments Overview
11.18.3 Quasar Instruments Drugs of Abuse Analysis Controls Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Quasar Instruments Drugs of Abuse Analysis Controls Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Quasar Instruments Recent Developments
11.19 BTNX
11.19.1 BTNX Corporation Information
11.19.2 BTNX Overview
11.19.3 BTNX Drugs of Abuse Analysis Controls Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 BTNX Drugs of Abuse Analysis Controls Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 BTNX Recent Developments
11.20 Bio-Rad Laboratories
11.20.1 Bio-Rad Laboratories Corporation Information
11.20.2 Bio-Rad Laboratories Overview
11.20.3 Bio-Rad Laboratories Drugs of Abuse Analysis Controls Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Bio-Rad Laboratories Drugs of Abuse Analysis Controls Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Bio-Rad Laboratories Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Drugs of Abuse Analysis Controls Industry Chain Analysis
12.2 Drugs of Abuse Analysis Controls Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Drugs of Abuse Analysis Controls Production Mode & Process
12.4 Drugs of Abuse Analysis Controls Sales and Marketing
12.4.1 Drugs of Abuse Analysis Controls Sales Channels
12.4.2 Drugs of Abuse Analysis Controls Distributors
12.5 Drugs of Abuse Analysis Controls Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Drugs of Abuse Analysis Controls Industry Trends
13.2 Drugs of Abuse Analysis Controls Market Drivers
13.3 Drugs of Abuse Analysis Controls Market Challenges
13.4 Drugs of Abuse Analysis Controls Market Restraints
14 Key Findings in The Global Drugs of Abuse Analysis Controls Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer